AbbVie and CytomX to co-develop Probody therapeutics
22 April 2016 | By Victoria White, Digital Content Producer
AbbVie and CytomX Therapeutics have entered into a collaboration to co-develop and co-commercialise Probody Drug Conjugates against CD71...